Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
InMed | INM | Sep 27, 2024 | 0.23 | 0.00 |
InMode | INMD | Sep 27, 2024 | 17.43 | +1.40 |
INmune Bio | INMB | Sep 27, 2024 | 5.22 | +5.24 |
Innate Pharma ADR | IPHA | Sep 27, 2024 | 2.20 | +2.33 |
Inno Holdings | INHD | Sep 27, 2024 | 0.53 | -3.62 |
Innodata | INOD | Sep 27, 2024 | 15.91 | -0.31 |
Innospec | IOSP | Sep 27, 2024 | 114.09 | +0.25 |
InnovAge | INNV | Sep 27, 2024 | 5.99 | +4.90 |
Innovate | VATE | Sep 27, 2024 | 3.95 | +1.02 |
Innovative Eyewear | LUCY | Sep 27, 2024 | 8.90 | +2.18 |
Innovative Industrial Properties | IIPR | Sep 27, 2024 | 135.82 | +0.25 |
Innovative Industrial Properties A Pref | IIPR-A | Sep 27, 2024 | 26.51 | +0.04 |
Innovative Solutions and Support | ISSC | Sep 27, 2024 | 6.61 | +3.28 |
Innovex International | INVX | Sep 27, 2024 | 14.96 | 0.00 |
Innovid | CTV | Sep 27, 2024 | 1.82 | +0.55 |
Innoviva | INVA | Sep 27, 2024 | 19.32 | +2.01 |
Innoviz Technologies | INVZ | Sep 27, 2024 | 0.79 | +1.29 |
InnSuites Hospitality | IHT | Sep 27, 2024 | 1.83 | +1.11 |
Inogen | INGN | Sep 27, 2024 | 9.69 | -0.62 |
Inotiv | NOTV | Sep 27, 2024 | 1.58 | +2.60 |
Inovio Pharmaceuticals | INO | Sep 27, 2024 | 5.86 | +6.35 |
Inozyme Pharma | INZY | Sep 27, 2024 | 5.18 | +0.78 |
Inpixon | XTIA | Sep 27, 2024 | 0.19 | -2.06 |
InPoint Commercial Real Estate Pref A | ICR-A | Sep 27, 2024 | 20.83 | -0.54 |
Inseego | INSG | Sep 27, 2024 | 17.49 | -1.24 |
Insight Enterprises | NSIT | Sep 27, 2024 | 213.06 | +0.63 |
Insight Select Income Fund | INSI | Sep 27, 2024 | 17.49 | +0.63 |
Insmed | INSM | Sep 27, 2024 | 72.48 | -0.54 |
Insperity | NSP | Sep 27, 2024 | 86.97 | +0.44 |
Inspira Technologies Oxy B.H.N. | IINN | Sep 27, 2024 | 1.39 | +9.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.